New Zealand markets closed

Oryzon Genomics SA (ORN.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
2.0050+0.1110 (+5.86%)
At close: 08:15AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-3,173
-3,706
-4,538
-5,307
-4,181
-
Depreciation & amortisation
-
168.998
178.7279
163.4146
178.4057
-
Change in working capital
-
-842.0925
1,347
2,416
-1,506
-
Inventory
-
4.1663
100.8032
241.206
-34.4706
-
Other working capital
-
-16,667
-17,285
-17,422
-17,269
-
Other non-cash items
-
2,144
1,117
648.2326
537.2589
-
Net cash provided by operating activities
-
-635.5618
-1,981
-4,106
-5,925
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-16,031
-15,304
-13,316
-11,344
-
Purchases of investments
-
-1.3541
-0.8568
-7.0073
0
-
Sales/maturities of investments
-
0.3007
0.1576
48.9187
174.1071
-
Other investing activities
-
-
-
-
174.1071
-
Net cash used for investing activities
-
-16,032
-15,305
-13,274
-11,170
-
Net change in cash
-
-10,015
-7,944
-12,319
5,527
-
Cash at beginning of period
-
23,564
30,804
44,841
43,185
-
Cash at end of period
-
13,549
22,860
32,523
48,712
-
Free cash flow
Operating cash flow
-
-635.5618
-1,981
-4,106
-5,925
-
Capital expenditure
-
-16,031
-15,304
-13,316
-11,344
-
Free cash flow
-
-16,667
-17,285
-17,422
-17,269
-